AbbVie Lowers 2024 Profit Forecast Amid $1.6B Acquisition Expenses
AbbVie reduces its 2024 profit outlook due to $1.6 billion in acquisition-related costs, impacting adjusted earnings. Discover the financial implications.
AbbVie has lowered its profit forecast due to acquisition-related expenses totaling $1.6 billion, impacting its adjusted earnings for 2024.